All Eyes On DOJ As Novartis FCA Deal Takes Shape

By Jeff Overley · October 27, 2015, 10:59 PM EDT

Novartis AG's tentative settlement Tuesday of kickback allegations for $390 million marked yet another huge False Claims Act payout that wasn't accompanied by punishment for individuals, and any final deal could indicate...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Related Sections

Case Information

Case Title

United States of America, ex rel, et al v. Novartis Pharmaceuticals Corporation

Case Number

1:11-cv-08196

Court

New York Southern

Nature of Suit

Other Statutes: False Claims Act

Date Filed

November 14, 2011